Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series

OBJECTIVE: Although the treatment of non-small-cell lung cancer (NSCLC) patients with human epidermal growth factor receptor 2 (HER2) alterations has been studied for years, the overall response rate (ORR) of these patients is still unsatisfactory, and more therapeutic strategies are needed. Little...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuang, Xian, Xinghong, Tian, Panwen, Li, Weimin, Wang, Ke, Li, Yalun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093620/
https://www.ncbi.nlm.nih.gov/pubmed/33959501
http://dx.doi.org/10.3389/fonc.2021.633522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093620/
https://www.ncbi.nlm.nih.gov/pubmed/33959501
http://dx.doi.org/10.3389/fonc.2021.633522

Ejemplares similares